The Gross Margin of OliX Pharmaceuticals Inc (226950.KQ) is 98.30%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 98.30% |
| 2023-12-31 | 97.78% |
| 2022-12-31 | 95.33% |
| 2021-12-31 | 98.29% |
| 2020-12-31 | 86.72% |